DataMEDS Completes First Compounded Peptide Sale
DataMEDS AI (NASDAQ:MEDS) announced that its Corexa Pharmacy subsidiary completed its first commercial sale of a compounded peptide under the U.S. Department of Health and Human…
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 9 06:46 ETSource: grafa.com
From the source
Read at grafa.comDataMEDS Completes First Compounded Peptide Sale
DataMEDS AI (NASDAQ:MEDS) announced that its Corexa Pharmacy subsidiary completed its first commercial sale of a compounded peptide under the U.S. Department of Health and Human Services' Enforcement Discretion Policy.
